{
  "title": "Practical Aspects of Using Large Language Models to Screen Abstracts for Cardiovascular Drug Development: Cross-Sectional Study",
  "url": "https://openalex.org/W4403123652",
  "year": 2024,
  "authors": [
    {
      "id": "https://openalex.org/A2644583666",
      "name": "Jay G Ronquillo",
      "affiliations": []
    },
    {
      "id": "https://openalex.org/A4211402569",
      "name": "Jamie Ye",
      "affiliations": []
    },
    {
      "id": "https://openalex.org/A2115670373",
      "name": "Donal Gorman",
      "affiliations": []
    },
    {
      "id": "https://openalex.org/A2436719811",
      "name": "Adina R Lemeshow",
      "affiliations": []
    },
    {
      "id": "https://openalex.org/A2108189184",
      "name": "Stephen J. Watt",
      "affiliations": []
    }
  ],
  "references": [
    "https://openalex.org/W4390571745",
    "https://openalex.org/W2128321405",
    "https://openalex.org/W4391723759",
    "https://openalex.org/W4397003633",
    "https://openalex.org/W4394579747",
    "https://openalex.org/W4395114882",
    "https://openalex.org/W4402391818",
    "https://openalex.org/W4395067526"
  ],
  "abstract": "Abstract Cardiovascular drug development requires synthesizing relevant literature about indications, mechanisms, biomarkers, and outcomes. This short study investigates the performance, cost, and prompt engineering trade-offs of 3 large language models accelerating the literature screening process for cardiovascular drug development applications.",
  "full_text": null,
  "topic": "Drug development",
  "concepts": [
    {
      "name": "Drug development",
      "score": 0.6149711012840271
    },
    {
      "name": "Computer science",
      "score": 0.5334449410438538
    },
    {
      "name": "Drug",
      "score": 0.5099388360977173
    },
    {
      "name": "Medicine",
      "score": 0.47784706950187683
    },
    {
      "name": "Process (computing)",
      "score": 0.47504425048828125
    },
    {
      "name": "Intensive care medicine",
      "score": 0.4273631274700165
    },
    {
      "name": "Risk analysis (engineering)",
      "score": 0.3938036262989044
    },
    {
      "name": "Data science",
      "score": 0.33264803886413574
    },
    {
      "name": "Pharmacology",
      "score": 0.16506865620613098
    },
    {
      "name": "Programming language",
      "score": 0.09368962049484253
    }
  ],
  "institutions": [
    {
      "id": "https://openalex.org/I180857899",
      "name": "Pfizer (United States)",
      "country": "US"
    },
    {
      "id": "https://openalex.org/I189718659",
      "name": "Pfizer (United Kingdom)",
      "country": "GB"
    }
  ]
}